Barr confirms Fentora tablet patent challenge Barr Pharmaceuticals.
Barr confirms Fentora tablet patent challenge Barr Pharmaceuticals, Inc. Provides verified that its subsidiary, Barr Laboratories, Inc., offers initiated a problem of the patents shown by Cephalon, Inc. Regarding the its Fentora Tablets , equal to fentanyl base 100 mcg, 400 mcg, 600 mcg and 800 mcg. Related StoriesMylan announces U.S. Start of generic Fusilev for InjectionImmune submits Bertilimumab IND software to FDA for treatment of Bullous PemphigoidKolltan announces display of data from KTN0158 preclinical research in mast cell tumors at ESMO 2015Barr filed its Abbreviated New Medication Application made up of a paragraph IV qualification for a generic Fentora item with the U.S.It takes a long time for a tumor to grow to the size where it could be detected on a mammogram. Meanwhile, doctors and medical personnel are bombarding your breasts with radiation every complete year, practically guaranteeing that you’ll end up getting breast tumor in your 60’s if you don’t die from something else first. Am I saying that government-run health care is out to kill you? Not exactly. But they sure aren’t attempting to keep you alive, either. Mainstream medicine may be the real killerYou know very well what the No. 1 killer in America is? It isn’t cancer.